Promotion of colorectal neoplasia in experimental murine ulcerative colitis

被引:203
作者
Okayasu, I
Ohkusa, T
Kajiura, K
Kanno, J
Sakamoto, S
机构
[1] TOKYO MED & DENT UNIV,DEPT INTERNAL MED 1,TOKYO 113,JAPAN
[2] TOKYO MED & DENT UNIV,DEPT PATHOL,TOKYO 113,JAPAN
[3] TOKYO MED & DENT UNIV,MED RES INST,TOKYO,JAPAN
关键词
ulcerative colitis; colorectal tumour; experimental colitis; dextran sulphate sodium;
D O I
10.1136/gut.39.1.87
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-The mechanisms underlying the frequent development of colorectal carcinomas in patients with ulcerative colitis are still unknown. Aims-To evaluate whether mucosal necrosis and regeneration act as enhancing or promoting factors in colorectal tumorigenesis, development of multiple colorectal tumours was studied in a murine model of ulcerative colitis with azoxymethane pretreatment. Methods-Periods of chronic ulcerative colitis in mice were induced by three repeated administrations of 3% dextran sulphate sodium subsequent to a single azoxymethane pretreatment, to give conditions similar to the clinically observed active and remission phases. Results-In the chronic colitis group with carcinogen exposure, multiple mucosal tumours (10.5/mouse) developed in the colorectum. This occurred primarily on the left side of the large intestine or transverse colon, the sites of the most severe colitic injury. The observed lesions were high grade dysplasias and invasive adenocarcinomas. Increased cell proliferation was evidenced by high uptake of bromodeoxyuridine, and increased activities of thymidylate synthetase and thymidine kinase. No tumours were induced in the control groups with azoxymethane pretreatment or chronic colitis alone. Conclusions-Repeated mucosal erosion with necrosis and regeneration is critical for the development of colorectal tumours in this experimental colitis system.
引用
收藏
页码:87 / 92
页数:6
相关论文
共 34 条
  • [1] [Anonymous], NONPARAMETRIC STAT B
  • [2] THE PROGNOSTIC SIGNIFICANCE OF DIRECT EXTENSION OF CARCINOMA OF THE COLON AND RECTUM
    ASTLER, VB
    COLLER, FA
    [J]. ANNALS OF SURGERY, 1954, 139 (06) : 846 - 852
  • [3] BOYLAND E, 1967, PROG EXP TUMOR RES, V11, P222
  • [4] COLONIC-CANCER INDUCED BY 1,2-DIMETHYLHYDRAZINE - PROMOTION BY EXPERIMENTAL COLITIS
    CHESTER, JF
    GAISSERT, HA
    ROSS, JS
    MALT, RA
    WEITZMAN, SA
    [J]. BRITISH JOURNAL OF CANCER, 1989, 59 (05) : 704 - 705
  • [5] DEXTRAN SULFATE SODIUM-INDUCED COLITIS OCCURS IN SEVERE COMBINED IMMUNODEFICIENT MICE
    DIELEMAN, LA
    RIDWAN, BU
    TENNYSON, GS
    BEAGLEY, KW
    BUCY, RP
    ELSON, CO
    [J]. GASTROENTEROLOGY, 1994, 107 (06) : 1643 - 1652
  • [6] DYSPLASIA AND MALIGNANCY IN INFLAMMATORY BOWEL-DISEASE
    DOBBINS, WO
    [J]. ANNUAL REVIEW OF MEDICINE, 1984, 35 : 33 - 48
  • [7] DUNLAP RB, 1971, BIOCHEMISTRY-US, V10, P88, DOI 10.1021/bi00777a014
  • [8] DEGRADED CARRAGEENAN-INDUCED COLITIS IN CF1 MICE - A CLINICAL, HISTOPATHOLOGICAL AND KINETIC-ANALYSIS
    FATH, RB
    DESCHNER, EE
    WINAWER, SJ
    DWORKIN, BM
    [J]. DIGESTION, 1984, 29 (04) : 197 - 203
  • [9] FIALA ES, 1975, CANCER, V36, P2407, DOI 10.1002/1097-0142(197512)36:6<2407::AID-CNCR2820360620>3.0.CO
  • [10] 2-W